Correspondence 0001493152-24-049252 from TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: Dec. 9, 2024 · CIK: 0001872812 · Accession: 0001493152-24-049252

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-283507

Date

Dec. 9, 2024

Author

Chief

Form

CORRESP

Company

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)

Letter

TC BIOPHARM (HOLDINGS) PLC

Maxim 1, 2 Parklands Way

Holytown, Motherwell ML1 4WR

Scotland, United Kingdom

December 9, 2024

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Lauren Hamill

Re: TC BioPharm (Holdings) plc

Registration Statement on Form F-3

File No. 333-283507

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Wednesday, December 11, 2024, or as soon thereafter as possible.

Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Very
truly yours,
TC
BIOPHARM (HOLDINGS) PLC

Show Raw Text

CORRESP
1
filename1.htm

TC
BIOPHARM (HOLDINGS) PLC

Maxim
1, 2 Parklands Way

Holytown,
Motherwell ML1 4WR

Scotland,
United Kingdom

December
9, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Lauren Hamill

    Re:
    TC
    BioPharm (Holdings) plc

    Registration
    Statement on Form F-3

    File
    No. 333-283507

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings)
plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:00 p.m., Eastern Time, on Wednesday, December 11, 2024, or as soon thereafter as
possible.

Please
notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Very
    truly yours,

    TC
    BIOPHARM (HOLDINGS) PLC

    By:
    /s/
    Bryan Kobel

    Name:
    Bryan
    Kobel

    Title:
    Chief
    Executive Officer

    - 1 -

SecProbe.io